Sunday, April 14, 2024 1:43:05 AM
"AstraZeneca is leading a revolution in cancer care, with the ambition to provide cures for cancer in every form, following the science to understand cancer and all its complexities to discover, develop and deliver life-changing medicines to patients."
Senior Director, Global Oncology Policy & Advocacy (GI Cancers)
https://careers.astrazeneca.com/job/gaithersburg/senior-director-global-oncology-policy-and-advocacy-gi-cancers/7684/62268377216
Director, Policy & Advocacy - Oncology
https://careers.astrazeneca.com/job/gaithersburg/director-policy-and-advocacy-oncology/7684/62038954976
"Help to advance our pipeline by applying expertise and accelerating our pathway to finding a cure."
Asset Lead, Oncology Outcomes Research (Breast)
https://careers.astrazeneca.com/job/gaithersburg/asset-lead-oncology-outcomes-research-breast/7684/61996298688
Senior Scientist, Oncology Outcomes Research
https://careers.astrazeneca.com/job/gaithersburg/senior-scientist-oncology-outcomes-research/7684/58983866848
Regional Oncology MSL Director, Gynecologic Cancers (WEST)
https://careers.astrazeneca.com/job/wilmington/regional-oncology-msl-director-gynecologic-cancers-west/7684/55871108688
Associate Director, Oncology Outcomes Research (GI)
https://careers.astrazeneca.com/job/gaithersburg/associate-director-oncology-outcomes-research-gi/7684/61033851008
Associate Director, Oncology Outcomes Research
https://careers.astrazeneca.com/job/gaithersburg/associate-director-oncology-outcomes-research/7684/59862306592
"Ambitious and collaborative, we're optimistic in our ability to be resilient and work together towards a cure."
Senior Scientist, Translational Proteomics, Mass Spectrometry
https://careers.astrazeneca.com/job/gaithersburg/senior-scientist-translational-proteomics-mass-spectrometry/7684/61555800448
Senior Scientist, Bioconjugation
https://careers.astrazeneca.com/job/gaithersburg/senior-scientist-bioconjugation/7684/61310462272
Recent NWBO News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/03/2024 08:01:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 08:01:24 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2024 09:06:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2024 08:30:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2024 02:42:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/30/2024 11:49:38 PM
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
ZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use • HALO • Oct 10, 2024 8:09 AM
CBD Life Sciences Inc. (CBDL) Targets Alibaba as the Next Retail Giant for Wholesale Expansion of Top-Selling CBD Products • CBDL • Oct 10, 2024 8:00 AM
Foremost Lithium Announces Option Agreement with Denison on 10 Uranium Projects Spanning over 330,000 Acres in the Athabasca Basin, Saskatchewan • FAT • Oct 10, 2024 5:51 AM
Element79 Gold Corp. Reports Significant Progress in Community Relations and Development Efforts in Chachas, Peru • ELEM • Oct 9, 2024 10:30 AM
Unitronix Corp Launches Share Buyback Initiative • UTRX • Oct 9, 2024 9:10 AM
BASANITE INDUSTRIES, LLC RECEIVES U.S. PATENT FOR ITS BASAFLEX™ BASALT FIBER COMPOSITE REBAR AND METHOD OF MANUFACTURING • BASA • Oct 9, 2024 7:30 AM